douglas clayton palmer
AstraZeneca (United States)
Wilmington, United States
Associate Editor
Cancer Immunity and Immunotherapy
AstraZeneca (United States)
Wilmington, United States
Associate Editor
Cancer Immunity and Immunotherapy
Bioinformatics Division, Walter and Eliza Hall Institute of Medical Research
Parkville, Australia
Associate Editor
Cancer Immunity and Immunotherapy
Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas
Madrid, Spain
Associate Editor
Cancer Immunity and Immunotherapy
Baylor College of Medicine
Houston, United States
Associate Editor
Cancer Immunity and Immunotherapy
Oslo University Hospital
Oslo, Norway
Associate Editor
Cancer Immunity and Immunotherapy
University of Texas MD Anderson Cancer Center
Houston, United States
Associate Editor
Cancer Immunity and Immunotherapy
Ecole Pratique des Hautes Etudes, Université Paris Sciences et Lettres
Paris, France
Associate Editor
Cancer Immunity and Immunotherapy
Jackson Laboratory for Genomic Medicine
Farmington, United States
Associate Editor
Cancer Immunity and Immunotherapy
Mayo Clinic
Rochester, United States
Associate Editor
Cancer Immunity and Immunotherapy
Johns Hopkins University
Baltimore, United States
Associate Editor
Cancer Immunity and Immunotherapy
Takeda Oncology
Cambridge, United States
Associate Editor
Cancer Immunity and Immunotherapy
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Associate Editor
Cancer Immunity and Immunotherapy
UmeĂĄ University
UmeĂĄ, Sweden
Associate Editor
Cancer Immunity and Immunotherapy
Owkin (France)
Paris, France
Associate Editor
Cancer Immunity and Immunotherapy
Moffitt Cancer Center
Tampa, United States
Associate Editor
Cancer Immunity and Immunotherapy
San Martino Hospital (IRCCS)
Genova, Italy
Associate Editor
Cancer Immunity and Immunotherapy